| Exosome-delivered microRNAs modulate the inflammatory response to endotoxin M Alexander, R Hu, MC Runtsch, DA Kagele, TL Mosbruger, ... Nature communications 6 (1), 7321, 2015 | 735 | 2015 |
| Tracking the clonal origin of lethal prostate cancer MC Haffner, T Mosbruger, DM Esopi, H Fedor, CM Heaphy, DA Walker, ... The Journal of clinical investigation 123 (11), 4918-4922, 2013 | 543 | 2013 |
| MYC drives progression of small cell lung cancer to a variant neuroendocrine subtype with vulnerability to aurora kinase inhibition G Mollaoglu, MR Guthrie, S Böhm, J Brägelmann, I Can, PM Ballieu, ... Cancer cell 31 (2), 270-285, 2017 | 463 | 2017 |
| Cellular immune selection with hepatitis C virus persistence in humans AL Cox, T Mosbruger, Q Mao, Z Liu, XH Wang, HC Yang, J Sidney, ... The Journal of experimental medicine 201 (11), 1741-1752, 2005 | 381 | 2005 |
| Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C AL Cox, T Mosbruger, GM Lauer, D Pardoll, DL Thomas, SC Ray Hepatology 42 (1), 104-112, 2005 | 319 | 2005 |
| Prospective evaluation of community-acquired acute-phase hepatitis C virus infection AL Cox, DM Netski, T Mosbruger, SG Sherman, S Strathdee, D Ompad, ... Clinical infectious diseases 40 (7), 951-958, 2005 | 315 | 2005 |
| A DNA hypermethylation module for the stem/progenitor cell signature of cancer H Easwaran, SE Johnstone, L Van Neste, J Ohm, T Mosbruger, Q Wang, ... Genome research 22 (5), 837-849, 2012 | 291 | 2012 |
| Humoral immune response in acute hepatitis C virus infection DM Netski, T Mosbruger, E Depla, G Maertens, SC Ray, RG Hamilton, ... Clinical infectious diseases 41 (5), 667-675, 2005 | 241 | 2005 |
| Transcriptome-wide profiling of multiple RNA modifications simultaneously at single-base resolution V Khoddami, A Yerra, TL Mosbruger, AM Fleming, CJ Burrows, BR Cairns Proceedings of the National Academy of Sciences 116 (14), 6784-6789, 2019 | 176 | 2019 |
| The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment G Mollaoglu, A Jones, SJ Wait, A Mukhopadhyay, S Jeong, R Arya, ... Immunity 49 (4), 764-779. e9, 2018 | 158 | 2018 |
| Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection CL Thio, TL Mosbruger, RA Kaslow, CL Karp, SA Strathdee, D Vlahov, ... Journal of virology 78 (20), 11258-11262, 2004 | 142 | 2004 |
| Mannose binding lectin genotypes influence recovery from hepatitis B virus infection CL Thio, T Mosbruger, J Astemborski, S Greer, GD Kirk, SJ O'Brien, ... Journal of virology 79 (14), 9192-9196, 2005 | 122 | 2005 |
| Genetic Protection against Hepatitis B Virus Conferred by CCR5Δ32: Evidence that CCR5 Contributes to Viral Persistence CL Thio, J Astemborski, A Bashirova, T Mosbruger, S Greer, MD Witt, ... Journal of virology 81 (2), 441-445, 2007 | 111 | 2007 |
| Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire M Wölfl, A Rutebemberwa, T Mosbruger, Q Mao, H Li, D Netski, SC Ray, ... The Journal of Immunology 181 (9), 6435-6446, 2008 | 83 | 2008 |
| Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus TL Mosbruger, P Duggal, JJ Goedert, GD Kirk, WK Hoots, LH Tobler, ... The Journal of infectious diseases 201 (9), 1371-1380, 2010 | 77 | 2010 |
| An analysis of tumor necrosis factor α gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection CL Thio, JJ Goedert, T Mosbruger, D Vlahov, SA Strathdee, SJ O'Brien, ... Genes & Immunity 5 (4), 294-300, 2004 | 75 | 2004 |
| CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription DJ Li, D Verma, T Mosbruger, S Swaminathan PLoS pathogens 10 (1), e1003880, 2014 | 67 | 2014 |
| FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer SA Camolotto, S Pattabiraman, TL Mosbruger, A Jones, VK Belova, ... Elife 7, e38579, 2018 | 65 | 2018 |
| miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response JA Wallace, DA Kagele, AM Eiring, CN Kim, R Hu, MC Runtsch, ... Blood, The Journal of the American Society of Hematology 129 (23), 3074-3086, 2017 | 64 | 2017 |
| Genome-wide CRISPR-Cas9 screen identifies microRNAs that regulate myeloid leukemia cell growth J Wallace, R Hu, TL Mosbruger, TJ Dahlem, WZ Stephens, DS Rao, ... Plos one 11 (4), e0153689, 2016 | 59 | 2016 |
